Evidence map›Paper›PMID 32238162›Full record

ArticleJournal of biomedical science2020

MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer.

Shine-Gwo Shiah, Jenn-Ren Hsiao, Hsiao-Ju Chang, Yuan-Ming Hsu, Guan-Hsun Wu, Hsuan-Yu Peng, Sung-Tau Chou, Ching-Chuan Kuo, Jang-Yang Chang

Open access · diamondAbstract read
In one paragraph

Article in Journal of biomedical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 89 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Deregulation of All-International journal of molecular sciences · 2023
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Shine-Gwo ShiahNational Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan.
Jenn-Ren HsiaoDepartment of Otolaryngology, Head and Neck Collaborative Oncology Group, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Hsiao-Ju ChangNational Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan.
Yuan-Ming HsuNational Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan.
Guan-Hsun WuNational Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan.
Hsuan-Yu PengNational Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan.
Sung-Tau ChouNational Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan.
Ching-Chuan KuoInstitute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli, Taiwan.
Jang-Yang ChangNational Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan. z10208083@email.ncku.edu.tw.
National Health Research Institutes · TWKaohsiung Medical University · TWNational Cheng Kung University Hospital · TW

Funding

Ministry of Health and Welfare MOHW 108-TDU-B-212-144013Ministry of Science and Technology, Taiwan MOST 101-2325-B-400-007Ministry of Science and Technology, Taiwan MOST 102-2325-B-400-007National Health Research Institutes NHRI-CA102-PP02National Health Research Institutes NHRI-CA-103-PP02
6 · The paper itself

Abstract

backgroundEpigenetic silencing of retinoic acid (RA) signaling-related genes have been linked with the pathogenesis and clinical outcome in oral squamous cell carcinoma (OSCC) carcinogenesis. However, the precise mechanisms underlying the abnormal silencing of RA signaling-related genes in OSCC have not been well investigated.

methodsUsing combined analysis of genome-wide gene expression and methylation profile from 40 matched normal-tumor pairs of OSCC specimens, we found a set of retinoid signaling related genes are frequently hypermethylated and downregulated in OSCC patient samples, including alcohol dehydrogenase, iron containing 1 (ADHFE1) and aldehyde dehydrogenase 1 family, member A2 (ALDH1A2), which are the important rate-limiting enzymes in synthesis of RA. The expression of ADHFE1 and ALDH1A2 in OSCC patients was determine by quantitative real-time PCR (qRT-PCR) and immunohistochemistry. The binding sites of miR-30a and miR-379 with DNA methyltransferase 3B (DNMT3B) were predicted using a series of bioinformatic tools, and validated using dual luciferase assay and Western blot analyses. The functions of miR-30a, miR-379, and DNMT3B were accessed by growth and colony formation analyses using gain- and loss-of-function approaches. Chromatin immunoprecipitation (ChIP) was performed to explore the molecular mechanisms by arecoline and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) treatment.

resultsWe demonstrated that deregulated miR-30a and miR-379 could represent a mechanism for the silencing of ADHFE1 and ALDH1A2 in OSCC through targeting DNMT3B. Ectopic expression of miR-30a and miR-379 could induce re-expression of methylation-silenced ADHFE1 and ALDH1A2, and lead to growth inhibition in oral cancer cells. Furthermore, the dysregulation of the miRNAs and DNMT-3B may result from exposure to tobacco smoking and betel quid chewing.

conclusionsOur results demonstrate that tobacco smoking and betel quid chewing could repress miR-30a and miR-379, which upregulate the DNMT3B expression, in turn, lead to the hypermethylation of ADHFE1 and ALDH1A genes, consequently, promote the oncogenic activity. These findings highlight the potential use of retinoids in combination with epigenetic modifiers for the prevention or treatment of oral cancer.

Indexed as

Gene SilencingAlcohol OxidoreductasesAldehyde Dehydrogenase 1 FamilyArecolineCarcinogenesisCarcinoma, Squamous CellCell Line, TumorDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3BGene Expression Regulation, NeoplasticHumansMetabolic Networks and PathwaysMicroRNAsMitochondrial ProteinsMouth NeoplasmsNitrosamines4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanoneAlcohol OxidoreductasesAldehyde Dehydrogenase 1 FamilyALDH1A2 protein, humanArecolineDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3Bhydroxyacid-oxoacid transhydrogenaseMicroRNAsMIRN30b microRNA, humanMIRN379 microRNA, humanMitochondrial ProteinsNitrosaminesRetinal DehydrogenaseTretinoinDNA methylationDNA methyltransferase (DNMT)Epigenetic regulationmicroRNAmiR-30aOral cancerOSCCRetinoic acid (RA)

Identifiers

PMID32238162
PMCPMC7114797
OpenAlexW3014412147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.